Cummings, Dr Fraser

Dr Fraser CummingsBMSc(Hons), MBChB, MRCP(UK), DPhil

Specialty

Gastroenterology

Sub-specialty

Inflammatory bowel disease

Training and education

  • BMSc (Hons), University of Dundee
  • MBChB, University of Dundee
  • Membership of the Royal College of Physicians (UK)
  • DPhil, University of Oxford
  • Junior house officer at Ninewells Hospital, Dundee and Dumfries and Galloway Royal Infirmary
  • Senior house officer at Western Infirmary, Glasgow and Glasgow Royal Infirmary
  • Registrar post, Oxford gastroenterology specialist registrar training rotation
  • Research at the Wellcome Trust Centre for Human Genetics and John Radcliffe Hospital, Oxford.

Experience

Dr Cummings has worked for the Trust since October 2009.

He is a busy consultant gastroenterologist at Southampton General Hospital doing a mix of ward work, outpatients, endsocopy and research. Dr Cummings looks after general gastroenterology patients and has a sub-specialty interest in inflamatory bowel disease (IBD). He spent five years developing this clinical and research interest at the John Radcliffe Hospital, Oxford, prior to starting work in Southampton. 

Key achievements

  • Clinical lead for IBD services with responsibility for not only running the IBD team including the nurse specialists, the IBD multi-disciplinary team, and the virtual clinic, but also developing the service to meet the national IBD standards of care.
  • Active research collaborations within the University of Southampton as well as externally, and principal investigator for two NIHR studies.

Research

  • Cummings JRF, Keshav S, Travis SPL. (2008). Medical management of Crohn’s Disease. British Medical Journal 2008 336 1062-66
  • Cummings JRF, Cooney R, Clarke G, Beckly J, Geremia A, Pathan S, Hancock L, Changcun G, Cardon LR, and Jewell DP. The Genetics of Nod-Like Receptors in Crohn's Disease. Tissue Antigens 2010 In press
  • Cummings JRF, Ahmad T, Geremia A, Beckly J, Cooney R, Hancock L, Pathan S, Guo C, Cardon LR, Jewell DP. Contribution of the novel IBD susceptibility gene IL23R to disease susceptibility and phentoype. Inflamm Bowel Dis. 2007; 13:1063-8
  • Cummings JRF, Cooney R, Pathan S, Anderson CA, Barrett JC, Beckly J, et al. Confirmation of the role of ATG16L1 as a Crohn's disease susceptibility gene. Inflamm Bowel Dis. 2007 13(8):941-6